# Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease

> **NCT07455578** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Seismic Therapeutic AU Pty Ltd** · enrollment: 24 (estimated)

## Conditions studied

- Autoimmune Diseases
- Rheumatoid Arthritis (RA)
- Psoriatic Arthritis (PsA)
- Psoriasis (PsO)
- Cutaneous Lupus Erythematosus (CLE)
- Atopic Dermatitis (AD)

## Interventions

- **DRUG:** S-4321

## Key facts

- **NCT ID:** NCT07455578
- **Lead sponsor:** Seismic Therapeutic AU Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07455578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07455578, "Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07455578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*